BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

603 related articles for article (PubMed ID: 29325618)

  • 1. Neurodegeneration with brain iron accumulation.
    Hayflick SJ; Kurian MA; Hogarth P
    Handb Clin Neurol; 2018; 147():293-305. PubMed ID: 29325618
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Analysis of the C19orf12 and WDR45 genes in patients with neurodegeneration with brain iron accumulation.
    Tschentscher A; Dekomien G; Ross S; Cremer K; Kukuk GM; Epplen JT; Hoffjan S
    J Neurol Sci; 2015 Feb; 349(1-2):105-9. PubMed ID: 25592411
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mitochondria: A crossroads for lipid metabolism defect in neurodegeneration with brain iron accumulation diseases.
    Aoun M; Tiranti V
    Int J Biochem Cell Biol; 2015 Jun; 63():25-31. PubMed ID: 25668476
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neurodegeneration with brain iron accumulation: Insights into the mitochondria dysregulation.
    Wang ZB; Liu JY; Xu XJ; Mao XY; Zhang W; Zhou HH; Liu ZQ
    Biomed Pharmacother; 2019 Oct; 118():109068. PubMed ID: 31404774
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pantothenate kinase-associated neurodegeneration (PKAN) and PLA2G6-associated neurodegeneration (PLAN): review of two major neurodegeneration with brain iron accumulation (NBIA) phenotypes.
    Kurian MA; Hayflick SJ
    Int Rev Neurobiol; 2013; 110():49-71. PubMed ID: 24209433
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel mutations in PANK2 and PLA2G6 genes in patients with neurodegenerative disorders: two case reports.
    Dastsooz H; Nemati H; Fard MAF; Fardaei M; Faghihi MA
    BMC Med Genet; 2017 Aug; 18(1):87. PubMed ID: 28821231
    [TBL] [Abstract][Full Text] [Related]  

  • 7. NBIA Syndromes: A Step Forward from the Previous Knowledge.
    Svetel M; Dragašević N; Petrović I; Novaković I; Tomić A; Kresojević N; Stanković I; Kostić V
    Neurol India; 2021; 69(5):1380-1388. PubMed ID: 34747818
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High frequency of beta-propeller protein-associated neurodegeneration (BPAN) among patients with intellectual disability and young-onset parkinsonism.
    Nishioka K; Oyama G; Yoshino H; Li Y; Matsushima T; Takeuchi C; Mochizuki Y; Mori-Yoshimura M; Murata M; Yamasita C; Nakamura N; Konishi Y; Ohi K; Ichikawa K; Terada T; Obi T; Funayama M; Saiki S; Hattori N
    Neurobiol Aging; 2015 May; 36(5):2004.e9-2004.e15. PubMed ID: 25744623
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A diagnostic approach for neurodegeneration with brain iron accumulation: clinical features, genetics and brain imaging.
    Salomão RP; Pedroso JL; Gama MT; Dutra LA; Maciel RH; Godeiro-Junior C; Chien HF; Teive HA; Cardoso F; Barsottini OG
    Arq Neuropsiquiatr; 2016 Jul; 74(7):587-96. PubMed ID: 27487380
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lifetime risk of autosomal recessive neurodegeneration with brain iron accumulation (NBIA) disorders calculated from genetic databases.
    Kolarova H; Tan J; Strom TM; Meitinger T; Wagner M; Klopstock T
    EBioMedicine; 2022 Mar; 77():103869. PubMed ID: 35180557
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical and genetic delineation of neurodegeneration with brain iron accumulation.
    Gregory A; Polster BJ; Hayflick SJ
    J Med Genet; 2009 Feb; 46(2):73-80. PubMed ID: 18981035
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neurodegeneration with brain iron accumulation.
    McNeill A; Chinnery PF
    Handb Clin Neurol; 2011; 100():161-72. PubMed ID: 21496576
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neurodegeneration associated with genetic defects in phospholipase A(2).
    Gregory A; Westaway SK; Holm IE; Kotzbauer PT; Hogarth P; Sonek S; Coryell JC; Nguyen TM; Nardocci N; Zorzi G; Rodriguez D; Desguerre I; Bertini E; Simonati A; Levinson B; Dias C; Barbot C; Carrilho I; Santos M; Malik I; Gitschier J; Hayflick SJ
    Neurology; 2008 Oct; 71(18):1402-9. PubMed ID: 18799783
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Update on neurodegeneration with brain iron accumulation.
    Popławska-Domaszewicz K; Florczak-Wyspiańska J; Kozubski W
    Neurol Neurochir Pol; 2014; 48(3):206-13. PubMed ID: 24981186
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neurodegeneration with Brain Iron Accumulation: Genetic Diversity and Pathophysiological Mechanisms.
    Meyer E; Kurian MA; Hayflick SJ
    Annu Rev Genomics Hum Genet; 2015; 16():257-79. PubMed ID: 25973518
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical and Imaging Presentation of a Patient with Beta-Propeller Protein-Associated Neurodegeneration, a Rare and Sporadic form of Neurodegeneration with Brain Iron Accumulation (NBIA).
    Hattingen E; Handke N; Cremer K; Hoffjan S; Kukuk GM
    Clin Neuroradiol; 2017 Dec; 27(4):481-483. PubMed ID: 28643035
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Indian-subcontinent NBIA: unusual phenotypes, novel PANK2 mutations, and undetermined genetic forms.
    Aggarwal A; Schneider SA; Houlden H; Silverdale M; Paudel R; Paisan-Ruiz C; Desai S; Munshi M; Sanghvi D; Hardy J; Bhatia KP; Bhatt M
    Mov Disord; 2010 Jul; 25(10):1424-31. PubMed ID: 20629144
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical, neuroimaging and genetic findings in Brazilian patients with neurodegeneration with brain iron accumulation.
    Araújo Salomão RP; Rezende Filho FM; Borges V; Kurian MA; Ferraz HB; Breedveld GJ; Bonifati V; Barsottini OG; Pedroso JL
    Parkinsonism Relat Disord; 2024 Jun; 123():106103. PubMed ID: 38582019
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neurodegeneration with brain iron accumulation: Characterization of clinical, radiological, and genetic features of pediatric patients from Southern India.
    Bhardwaj NK; Gowda VK; Saini J; Sardesai AV; Santhoshkumar R; Mahadevan A
    Brain Dev; 2021 Nov; 43(10):1013-1022. PubMed ID: 34272103
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Syndromes of neurodegeneration with brain iron accumulation (NBIA): an update on clinical presentations, histological and genetic underpinnings, and treatment considerations.
    Schneider SA; Hardy J; Bhatia KP
    Mov Disord; 2012 Jan; 27(1):42-53. PubMed ID: 22031173
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 31.